MakroCare is organizing the webinar on Risk Management EU MDR Perspective. This webinar is designed to focus on the Risk management system should be carefully aligned with and reflected in the clinical evaluation for the device, including the process of clinical risks that needs to be addressed as part of clinical investigations, clinical evaluation and post-market clinical follow up.
MakroCare is organizing the webinar on Medical Device PMS & PMCF: Challenges & Opportunities. This webinar will focus on pitfalls and challenges in planning, conducting, and managing PMCF studies.
Manufacturers of Medical Devices are required to report to the FDA when they learn that any of their devices may have caused or contributed to a death or serious injury. Manufacturers must also report to the FDA when they become aware that their device has malfunctioned and would be likely to cause or contribute to a death or serious injury if the malfunction was to be reoccur.
The Article 45 of the Law of Ukraine “On technical regulation and conformity assessment” approves possibility of recognition of conformity assessment results conducted outside Ukraine. It is important that procedure is not unconditional, in other words it is not possible to exchange EC certificate to UA certificate. Only part of the assessment performed in EU can be accepted in Ukraine. Recognition procedure is sufficiently regulated in the national legislation but requires a deep understanding, both from the designated conformity assessment body and from the manufacturer. There are many particularities and limitations that should be considered before the start of certification, and taken into account throughout the entire circulation of products on the Ukrainian market.
Compliance Trainings would provide training on various concepts like Class I, II and III devices, 510(k), Premarket Approval (PMA), IVD’s (In Vitro Diagnostics) and Current Good Manufacturing Practices (cGMP).